Abstract:That cancer cells show patterns of metabolism different from normal cells has been known for over 50 years. Yet, it is only in the past decade or so that an appreciation of the benefits of these changes has begun to emerge. Altered cancer cell metabolism was initially attributed to defective mitochondria. However, we now realize that most cancers do not have mitochondrial mutations and that normal cells can transiently adopt cancer-like metabolism during periods of rapid proliferation. Indeed, an encompassing, albeit somewhat simplified, conceptual framework to explain both normal and cancer cell metabolism rests on several simple premises. First, the metabolic pathways used by cancer cells and their normal counterparts are the same. Second, normal quiescent cells use their metabolic pathways and the energy they generate largely to maintain cellular health and organelle turnover and, in some cases, to provide secreted products necessary for the survival of the intact organism. By contrast, undifferentiated cancer cells minimize the latter functions and devote their energy to producing the anabolic substrates necessary to maintain high rates of unremitting cellular proliferation. Third, as a result of the uncontrolled proliferation of cancer cells, a larger fraction of the metabolic intermediates normally used by quiescent cells purely as a source of energy are instead channeled into competing proliferation-focused and energy-consuming anabolic pathways. Fourth, cancer cell clones with the most plastic and rapidly adaptable metabolism will eventually outcompete their less well-adapted brethren during tumor progression and evolution. This attribute becomes increasingly important as tumors grow and as their individual cells compete in a constantly changing and inimical environment marked by nutrient, oxygen, and growth factor deficits. Here, we review some of the metabolic pathways whose importance has gained center stage for tumor growth, particularly those under the control of the c-Myc (Myc) oncoprotein. We discuss how these pathways differ functionally between quiescent and proliferating normal cells, how they are kidnapped and corrupted during the course of transformation, and consider potential therapeutic strategies that take advantage of common features of neoplastic and metabolic disorders.

The hallmarks of cancer metabolism: Still emerging

The Emerging Hallmarks of Cancer Metabolism

Dysregulated metabolism contributes to oncogenesis

Computational modeling of cancer cell metabolism along the catabolic-anabolic axes

Altered metabolism in cancer: insights into energy pathways and therapeutic targets

Cancer metabolism and carcinogenesis

Systems biology analysis of drivers underlying hallmarks of cancer cell metabolism

Cancer Metabolism: Phenotype, Signaling and Therapeutic Targets

Connections between metabolism and epigenetics in cancers

Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

Cancer Metabolism and Dietary Interventions

Targeting the Dynamics of Cancer Metabolism in the Era of Precision Oncology.

Metabolic reprogramming in tumors: Contributions of the tumor microenvironment

New Metabolomic Insights Into Cancer

Mechanisms of Metabolic Reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation

Proteomics Revisits the Cancer Metabolome

The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: Recent advances and future perspectives

The metabolic addiction of cancer stem cells

Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics

Regulatory Role of Cancer Microenvironment in Cancer Metabolism

The Role for Myc in Coordinating Glycolysis, Oxidative Phosphorylation, Glutaminolysis, and Fatty Acid Metabolism in Normal and Neoplastic Tissues